Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone in Hemodialysis Patients (MiREnDa)
NCT01691053Phase 2Completed
- Start
- Dec 2012
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of spironolactone in end stage renal disease (ESRD). Started Dec 2012; status: completed.
02
Drugs
spironolactone
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT01691053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01691053.